17/06/2021
Vaccine development efforts primarily focus on the generation of neutralizing antibodies that block viral entry, as illustrated by the success of SARS-CoV-2 vaccines. However, this strategy has yielded disappointing results for herpes simplex virus (HSV). This webinar will discuss the role of antibody-dependent cell mediated cytotoxicity (ADCC) and antibody dependent cell-mediated phagocytosis (ADCP) in HSV vaccine development. The webinar will include a live Q&A session.
You will learn about:
•The efficacy of neutralizing and non-neutralizing antibodies in mediating protection varies for different viruses
•Non-neutralizing (ADCP) antibodies may contribute to disease pathogenesis, as suggested by studies with coronaviruses
•HVEM plays a central role in generating and mediating ADCC
Registration link :https://bit.ly/3hEJswA Free Registration
Media mikrobiologi adalah tulang punggung setiap laboratorium yang terlibat dalam studi atau aplikasi mikroorganisme. Fungsi…
Indolab Utama menghadirkan penawaran spesial akhir tahun!Dapatkan diskon hingga 50% untuk berbagai produk laboratorium pilihan.…
Seiring meningkatnya volume sampel, terutama dalam studi genetik skala besar (genomik) dan uji diagnostik klinis…
Indolab Utama baru saja menyelesaikan training seru Isolasi DNA menggunakan kit A1120 di UMMADA Cirebon!…
Kami bangga menjalin kolaborasi dengan RSUD Koja dalam meningkatkan layanan patologi mereka. Indolab Utama telah…
Fenomena bioluminescence, yaitu produksi cahaya oleh organisme hidup melalui reaksi kimia, telah lama memukau manusia…